| Number |
11 (78.57%) |
3 (21.43%) |
|
| Mean age (a) |
49±9 |
56.67±2.67 |
0.184 |
| Number receiving antiretroviral therapy |
10 (90.91%) |
N/A |
|
| Mean dose of ethambutol (mg/kg/ day) |
17.25±1.23 |
17.12±1.01 |
0.873 |
| Duration of therapy (month) |
5.64± 2.9 |
6.67±1.15 |
0.568 |
| Number presenting less than one month after onset of symptoms |
5 (45.45%) |
2 (66.67%) |
0.347 |
| Number with renal impairment |
1 |
0 |
0.588 |
| Mean visual acuity at presentation |
|
|
|
| Right |
1.89±0.58 |
1.66±0.577 |
0.56 |
| Left |
1.91±0.3 |
1.66±0.577 |
|
| Ishihara score at presentation |
Test plate only (all) |
Test plate only (all) |
0.32 |
| Number showing visual recovery |
5 (45.45%) |
2 (66.67%) |
0.347 |
| Mean visual acuity improvement |
|
|
|
| Right |
1.07±0.43 |
0.6±0.85 |
0.561 |
| Left |
0.88±0.59 |
1.2±0 |
0.325 |
| Ishihara score improvement |
|
|
|
| Right |
9.75±2.87 |
3.5±3.53 |
0.0759 |
| Left |
6.75±4.11 |
5±1.41 |
0.558 |
